The ‘egg timer’ blood test is marketed as an empowering way to give women insights to help them plan when to have children. Problem is, it can’t deliver what it promises.
Academic rigour, journalistic flair
Articles on Ovarian cancer
Displaying 1 - 20 of 34 articles
Kath O'Connor’s debut novel, Inheritance, follows two women – an IVF hopeful and her grandmother – who carry the BRCA1 gene and contract ovarian cancer. It’s very close to being memoir.
There are currently no effective tests to screen for ovarian cancer. But that doesn’t mean there aren’t ways to recognize and prevent it.
I was motivated to improve the outcome for women with ovarian cancer by my experience as a junior doctor in London in 1985. But 36 years on, the results aren’t what we’d hoped.
Regular testing can mean potentially fatal diseases can be picked up and treated early.
We need to change diagnosis of ovarian cancer from late stage to early - scientists make steps
Having children is linked to a greater risk of heart attacks and stroke, but kids aren’t completely bad for your health.
A urine test for ovarian cancer could increase survival rates from 20% to 90%.
Mutations in BRCA genes are linked to the early onset of breast and ovarian cancers. But the effect of most mutations is unclear. Now new research can distinguish harmless from dangerous mutations.
There are currently few effective and non-invasive methods to screen for early stages of cancer. But scientists have now developed a new blood test that promises to detect eight different cancers.
Something exciting is going on – no thanks to the supplements industry.
Scientists are making the terrifying useful.
Some studies have found a link between the long-term use of talcum powder as a feminine hygiene product and an increased risk of ovarian cancer.
The rate of Australians dying from cancer is on a steady, downhill trajectory, thanks to powerful advances made in prevention, diagnosis and treatment of the disease.
What if you could take a simple test to reveal your individual risk of developing a range of cancers and hundreds of other diseases?
Jolie Pitt has announced more surgery, this time to mitigate her risk of developing ovarian cancer. But this should ideally not have the same “Jolie effect” as her last operation.
Genetic testing for cancer will become more common and risk reducing surgery is one way to cut the risk.
It is well established that faults in the BRCA2 gene (and the BRCA1 gene that prompted actress Angelina Jolie to undergo a mastectomy) increase the risk of breast, ovarian, prostate and other cancers…
Ovarian cancer is the fifth highest killer in women when it comes to cancer, according to statistics from the American Cancer Society, with about 14,000 deaths in the United States alone this year. The…
Most cancers happen by chance and there is no obvious inherited reason for them. However a small proportion of cancers occur as a result of a genetic predisposition because a gene passed down through generation…
Job Board
-
Student Recruitment Coordinator, Equity
-
Lecturer/ Senior Lecturer, Information Technology
-
Commissioning Editor, Health
-
Research Fellow/Senior Research Fellow
-
Executive Dean, Faculty of Arts & Design
Top contributors
-
Consultant Senior Lecturer in Clinical Genetics, UCL
-
Professorial Research Fellow. School of Psychology, Faculty of Health and Medical Sciences, University of Adelaide
-
Medical Oncologist and Laboratory Head, Walter and Eliza Hall Institute
-
Clinical Professorial Research Fellow, The University of Queensland
-
Emeritus Professor, Australian Research Centre in Sex, Health and Society, La Trobe University
-
Adjunct Professor, Australian Centre for Health Law Research, School of Law, Queensland University of Technology
-
NHMRC Emerging Leader Research Fellow, University of Sydney
-
Executive Director, Melbourne Genomics Health Alliance, Walter and Eliza Hall Institute
-
Professor of Oncology, Head of the RMH Familial Cancer Centre and Joint Head, Breast Cancer Laboratory, Walter and Eliza Hall Institute
-
Adjunct Professor, School of Psychology, Curtin University and College of Health and Medicine, Australian National University
-
Senior Manager, Descriptive Epidemiology, Cancer Council Queensland
-
Professor of Biochemistry, University of Aberdeen
-
Dean, Graduate Research, University of Canberra
-
Senior Lecturer and Consultant in Gynaecological Oncology, Imperial College London
-
Senior Research Fellow, Global and Women's Health, School of Public Health & Preventive Medicine, Monash University
